CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 80 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,079,000 | +11.4% | 286,334 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,867,000 | +18.8% | 287,248 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,571,000 | +51.3% | 287,797 | +29.7% | 0.00% | +100.0% |
| Q1 2016 | $1,038,000 | -4.1% | 221,901 | +2.1% | 0.00% | 0.0% |
| Q4 2015 | $1,082,000 | +33.6% | 217,369 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $810,000 | -38.8% | 215,377 | -2.2% | 0.00% | -50.0% |
| Q2 2015 | $1,323,000 | +49.8% | 220,166 | +39.7% | 0.00% | +100.0% |
| Q1 2015 | $883,000 | +89.5% | 157,602 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $466,000 | +11.5% | 155,218 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $418,000 | -5.4% | 155,954 | -1.3% | 0.00% | 0.0% |
| Q2 2014 | $442,000 | -31.5% | 158,013 | +6.8% | 0.00% | 0.0% |
| Q1 2014 | $645,000 | +37.5% | 147,964 | +1.3% | 0.00% | 0.0% |
| Q4 2013 | $469,000 | +98.7% | 146,017 | -1.5% | 0.00% | – |
| Q3 2013 | $236,000 | +0.4% | 148,186 | +9.0% | 0.00% | – |
| Q2 2013 | $235,000 | – | 135,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |